Chemistry of Heterocyclic Compounds

, Volume 47, Issue 7, pp 826–832 | Cite as

4-hydroxy-2-quinolones. 197*. The search for novel diuretics amongst halo-substituted 6-hydroxy-2-methyl-4-oxo-1,2-dihydro-4H-pyrrolo-[3,2,1-ij]quinoline-5-carboxylic acid anilides

  • I. V. UkrainetsEmail author
  • N. Yu. Golik
  • A. L. Shemchuk
  • O. I. Naboka
  • Yu. V. Voronina
  • A. V. Turov

A targeted synthesis of a series of halo-substituted 6-hydroxy-2-methyl-4-oxo-1,2-dihydro-4H-pyrrolo-[3,2,1-ij]quinoline-5-carboxylic acid anilides have been carried out. Peculiarites of the 1H NMR spectra and the results of investigating the diuretic activity of these compounds are discussed.


anilides 4-hydroxy-2-oxoquinoline-3-carboxylic acids methylindoline amidation diuretic activity 


  1. 1.
    I. V. Ukrainets, E. V. Mospanova, A. V. Turov, and V. A. Parshikov, Khim. Geterotsikl. Soedin., 885 (2011).Google Scholar
  2. 2.
    J. M. Pascual, E. Rodilla, J. A. Costa, F. Perez-Lahiguera, C. Gonzalez, E. Lurbe, and J. Redón, Blood Pressure, 18, 247 (2009).Google Scholar
  3. 3.
    E. Rodilla, J. A. Costa, F. Pérez-Lahiguera, C. González, and J. M. Pascual, Med. Clin. (Barcelona), 131, 406 (2008).CrossRefGoogle Scholar
  4. 4.
    L. Ghiadoni, Expert Opin. Pharmacother., 11, 1647 (2010).CrossRefGoogle Scholar
  5. 5.
    T. Ninomiya, S. Zoungas, B. Neal, M. Woodward, A. Patel, V. Perkovic, A. Cass, M. Cooper, D. Grobbee, P. Hamet, S. Harrap, L. Liu, G. Mancia, C.-E. Mogensen, N. Poulter, A. Rodgers, B. Williams, S. MacMahon, and J. Chalmers, J. Hypertens., 28, 1141 (2010).Google Scholar
  6. 6.
    H. Yamada, Y. Mishiro, K. Kusunose, and M. Sata, J. Cardiovasc. Pharmacol. Ther., 15, 145 (2010).CrossRefGoogle Scholar
  7. 7.
    Y. Hasegawa, K. Shimada, and T. Yamaguchi, Blood Pressure, Suppl., 19, 10 (2010).Google Scholar
  8. 8.
    S. A. Brandão, M. C. Izar, S. M. Fischer, A. O. Santos, C. M. Monteiro, R. M. Póvoa, T. Helfenstein, A. C. Carvalho, A. M. Monteiro, E. Ramos, M. Gidlund, A. M. Figueiredo Neto, and F. A. Fonseca, Am. J. Hypertens., 23, 208 (2010).CrossRefGoogle Scholar
  9. 9.
    H. Arima, C. Anderson, T. Omae, L. Liu, C. Tzourio, M. Woodward, S. Macmahon, B. Neal, A. Rodgers, and J. Chalmers, J. Hypertens., 28, 395 (2010).CrossRefGoogle Scholar
  10. 10.
    A. Kleemann and J. Engel, Pharmaceutical Substances. Synthesis, Patents, Applications, Multimedia Viewer, Version 2.00, Georg Thime Verlag, Stuttgart (2001).Google Scholar
  11. 11.
    E. V. Mospanova, Diss. Cand. Pharmaceut. Sci., Kharkiv (2008).Google Scholar
  12. 12.
    I. V. Ukrainets, N. Yu. Golik, K. V. Andreeva, and O. V. Gorokhova, Khim. Geterotsikl. Soedin., 1806 (2010). [Chem. Heterocycl. Comp., 46, 1459 (2010)].Google Scholar
  13. 13.
    M. Karplus, J. Chem. Phys., 30, 11 (1959).CrossRefGoogle Scholar
  14. 14.
    L. N. Sernov and V. V. Gatsura, Elements of Experimental Pharmacology [in Russian], Moscow, 2000, p. 103.Google Scholar
  15. 15.
    M. D. Mashkovskii, Drugs, RIA, Novaya Volna, Umerenkov Publishing House, Moscow, 2009, p. 499.Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2011

Authors and Affiliations

  • I. V. Ukrainets
    • 1
    Email author
  • N. Yu. Golik
    • 1
  • A. L. Shemchuk
    • 1
  • O. I. Naboka
    • 1
  • Yu. V. Voronina
    • 1
  • A. V. Turov
    • 2
  1. 1.National University of PharmacyKharkivUkraine
  2. 2.Taras Shevchenko National UniversityKyivUkraine

Personalised recommendations